Curative propensity of green tea extract towards hepatic fibrosis induced by CCl4: A histopathological study Corrigendum in /etm/10/2/835

Safer,A. M.; Afzal,M.; Hanafy,N.; Sosamma,O.; Mousa,S. A.

doi:10.3892/etm.2012.503

Curative propensity of green tea extract towards hepatic fibrosis induced by CCl4: A histopathological study

Corrigendum in: /etm/10/2/835

Authors:
- A. M. Safer
- M. Afzal
- N. Hanafy
- O. Sosamma
- S. A. Mousa
View Affiliations

Affiliations: Department of Biological Sciences, Faculty of Science, Kuwait University, Kuwait City, State of Kuwait, The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA
Published online on: March 2, 2012 https://doi.org/10.3892/etm.2012.503
Pages: 781-786

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic fibrosis constitutes a serious insult to the liver, with a substantial negative impact on the quality of life of such patients worldwide. It is a consequence of severe liver damage and occurs as the result of several factors. Chronic alcoholism is the most common cause. Fibrosis also results from chronic viral hepatitis and autoimmune hepatitis. Prolonged exposure to environmental toxins such as carbon tetrachloride (CCl4) can also lead to fibrosis. In the present study, the hepato-protective effects of green tea extract (GTE) on hepatic fibrosis in a rat liver CCl4-induced fibrosis model were examined histologically, 3-dimensionally and biochemically. GTE was prepared from dried green tea leaves and lyophilized. Male albino rats (n=20) weighing 200-250 g were divided into four groups: GI, control; GII, administered 50 mg/kg GTE dissolved in physiological saline daily for four weeks; GIII, administered 40% CCl4 (1 ml/kg body weight) by subcutaneous injection daily for four weeks; and GIV, treated as GIII, followed by 50 mg/kg GTE dissolved in physiological saline daily for four weeks. Histology and 3-dimensional scanning electron microscopy showed hepatic fibrosis with intermingled fibers located between cells in the liver tissues of the CCl4-treated rats. Fibrotic lesions virtually disappeared after four weeks of treatment with GTE, returning the architecture of liver tissue back to its normal state. Also, the levels of the hepatic enzymes alanine aminotranferase and aspartate aminotransferase returned to their normal levels after treatment with GTE. The rats were found to regain their normal body weight and their fur color, which had faded due to weight loss. The autopsy results showed the animal liver returning to normal shape and color. Thus, green tea extract is a potent treatment for hepatic fibrosis caused by CCl4 in this animal model.

View Figures

View References

1.	Paz Z and Shoenfeld Y: Anti-fibrosis: to reverse the irreversible. Clin Rev Allergy Immunol. 38:276–286. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Bateller R and Brenner DA: Liver fibrosis. J Clin Invest. 115:209–218. 2005. View Article : Google Scholar
3.	Bissell DM: Hepatic fibrosis as wound repair: a progress report. J Gastroenterol. 33:295–302. 1998. View Article : Google Scholar : PubMed/NCBI
4.	Kim HK, Yang TH and Cho HY: Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol. 15:5200–5205. 2009. View Article : Google Scholar : PubMed/NCBI
5.	Li CH, Piao DM, Xu WX, Yin ZR, Jin JS and Shen ZS: Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats. World J Gastroenterol. 28:7620–7624. 2005.PubMed/NCBI
6.	Wu J and Zern MA: Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 35:665–672. 2000. View Article : Google Scholar : PubMed/NCBI
7.	Al-Bloushi S, Safer AM, Afzal M and Shaker M: Green tea modulates reserpine toxicity in animal model. J Toxicol Sci. 34:77–87. 2009. View Article : Google Scholar : PubMed/NCBI
8.	Safer AM, Afzal M, Al-Bloushi S, Rafique M and Mousa SA: Inhibition property of green tea extract in relation to reserpine-induced ribosomal strips of rough endoplasmic reticulum (rER) of the rat kidney proximal tubule cells. J Toxicol Sci. 34:637–645. 2009. View Article : Google Scholar
9.	Wang XH, Zhao J, Zhang W, Zhang L, Ma R, Wang L, Zhang S and Tian L: Scanning electron microscopic observation: three-dimensional architecture of the collagen in hepatic fibrosis rats. Chin Med J. 120:308–312. 2007.PubMed/NCBI
10.	Borrelli F, Capasso R, Russo A and Ernst E: Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther. 19:497–510. 2004. View Article : Google Scholar : PubMed/NCBI
11.	Cooper R, Morre DJ and Morre DM: Medicinal benefits of green tea: part I. Review of non-cancer health benefits. J Altern Complement Med. 11:521–528. 2005. View Article : Google Scholar : PubMed/NCBI
12.	Fujita H and Yamagami T: Anti-hypercholesterolemia effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res. 28:450–456. 2008. View Article : Google Scholar : PubMed/NCBI
13.	Gross G, Meyer KG, Pres H, Thielert C, Tawfik H and Mescheder A: A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol. 2:1404–1412. 2007. View Article : Google Scholar
14.	Inoue M, Tajima K and Mizutani M: Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 167:175–182. 2001. View Article : Google Scholar
15.	Jian L, Xie LP, Lee AH and Binns CW: Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer. 108:130–135. 2004. View Article : Google Scholar : PubMed/NCBI
16.	Jin X, Zheng RH and Li YM: Green tea consumption and liver disease: a systematic review. Liver Int. 28:990–996. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA and Nash RJ: Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem. 56:8206–8211. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Kovacs EM, Lejeune MP, Nijs I and Westerterp-Plantenga MS: Effects of green tea on weight maintenance after body-weight loss. Br J Nutr. 91:431–437. 2004. View Article : Google Scholar : PubMed/NCBI
19.	Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y and Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA. 296:1255–1265. 2006. View Article : Google Scholar : PubMed/NCBI
20.	Low Dog T, Riley D and Carter T: Traditional and alternative therapies for breast cancer. Altern Ther Health Med. 7:36–47. 2001.PubMed/NCBI
21.	Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF and Hammons GJ: Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer. 35:80–86. 1999. View Article : Google Scholar : PubMed/NCBI
22.	Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, Tsuji I, Tanaka K, Mizoue T, Nagata C, et al: Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut. 58:1323–1332. 2009. View Article : Google Scholar : PubMed/NCBI
23.	Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umeqaki K, Hara Y, Ikeda M and Tomita T: Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 131:27–32. 2001.PubMed/NCBI
24.	Nagao T, Hase T and Tokimitsu I: A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 15:1473–1483. 2007. View Article : Google Scholar : PubMed/NCBI
25.	Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P and Mallat A: Hepatic fibrosis molecular mechanisms and drug targets (Review). Annu Rev Pharmacol Toxicol. 45:605–628. 2005. View Article : Google Scholar : PubMed/NCBI
26.	Gressner AM: The cell biology of liver fibrogenesis – an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res. 292:447–452. 1998.
27.	Oh SW, Kim DH, Ha JR and Kim DY: Anti-fibrotic effects of a methylenedioxybenzene compound, CW209292 on dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull. 32:1364–1370. 2009. View Article : Google Scholar : PubMed/NCBI
28.	Yang CS: Tea and health. Nutrition. 15:946–949. 1999.
29.	Ohta Y, Kongo M, Sasaki E, Nishida K and Ishiguro I: Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. J Pineal Res. 28:119–126. 2000. View Article : Google Scholar : PubMed/NCBI
30.	Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP and Rice-Evans C: Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys. 322:339–346. 1995. View Article : Google Scholar : PubMed/NCBI
31.	Gouni-Berthold I and Sachinidis A: Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. Curr Pharm Des. 10:1261–1271. 2004. View Article : Google Scholar : PubMed/NCBI
32.	Mandel S and Youdim MB: Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med. 37:304–317. 2004. View Article : Google Scholar : PubMed/NCBI